oral glp-1 weight loss Patients taking an experimental drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other FDA Approves First-Of-Its-Kind Oral GLP-1

Without adequate collagen, these tissues lose their integrity, leading to joint discomfort, longer recovery times, and visible signs of aging like fine lines

ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)

Treatment Consistency Regular sessions usually provide better outcomes than irregular treatment

Multivariate Behav Res (2011) 46(3):399424

Pain in Hashimotos is often the result of inflammation

Research Notes Teichman et al